This triple-combination inhaler is a prescription medication used for the long-term management of Chronic Obstructive Pulmonary Disease (COPD) and moderate to severe asthma. It brings together three agents that target different aspects of airway obstruction and inflammation:

• Tiotropium Bromide – a long-acting muscarinic antagonist (LAMA) that helps keep airways open by blocking bronchoconstriction.
• Formoterol Fumarate – a long-acting beta-2 agonist (LABA) that relaxes airway smooth muscles, allowing for easier breathing and better airflow.
• Ciclesonide – an inhaled corticosteroid (ICS) that reduces inflammation and swelling in the airways, helping prevent asthma attacks and COPD flare-ups.

Together, this combination provides broad-spectrum control by improving lung function, reducing symptoms like wheezing and breathlessness, and lowering the risk of disease exacerbations. It is ideal for patients who require multi-drug therapy in a single inhaler to simplify treatment and enhance adherence.